TITLE

An abdominal pain syndrome in a lupus patient

AUTHOR(S)
Cornelis, T.; Breynaert, C.; Blockmans, D.
PUB. DATE
February 2008
SOURCE
Clinical Rheumatology;Feb2008, Vol. 27 Issue 2, p257
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Systemic lupus erythematosus can be complicated by the antiphospholipid syndrome (APS). The clinical manifestations of this syndrome most often documented thus far are recurrent deep venous thrombosis, recurrent spontaneous abortions, and cerebral vascular accidents. Abdominal ischemic events have received relatively little attention in prior reports. We report on a lupus patient with lupus anticoagulant positivity who presented with abdominal pain, anorexia, and weight loss who was subsequently diagnosed with gastric ulcers and pancreatitis. Computerized tomography of the abdomen in addition revealed splenic and kidney infarcts. We conclude that this patient had (ischemic) chronic pancreatitis with pseudocysts and splenic and renal infarcts probably due to secondary APS.
ACCESSION #
37137803

 

Related Articles

  • Kingella endocarditis and meningitis in a patient with SLE and associated antiphospholipid syndrome. Wolak, T.; Abu-Shakra, M.; Flusser, D.; Liel-Coheon, N.; Buskila, D.; Sukenik, S. // Lupus;2000, Vol. 9 Issue 5, p393 

    We describe a patient with SLE and antiphospholipid syndrome who presented with severe headache and fever. Lumbar puncture analyses indicated meningitis. Kingella kingae was isolated from her blood cultures. A large mobile vegetation was seen on her mitral valve. The association between SLE,...

  • Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients. Lefèvre, G; Lambert, M; Bacri, J-L; Dubucquoi, S; Quemeneur, T; Caron, C; Launay, D; Houfflin-Debarge, V; Hachulla, E; Kyndt, X; Subtil, D; Hatron, P-Y // Lupus;Jul2011, Vol. 20 Issue 8, p861 

    Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by arterial and/or venous thromboses and/or pregnancy-associated morbidity. Some patients develop only obstetric complications (obstetric APS), but data on the frequency of thrombotic events during the follow-up of...

  • PARAOXONASE ACTIVITY (PXa) CORRELATES WITH ANTICARDIOLIPIN ANTIBODIES IN APS.  // Lupus;Jan2001 Supplement 1, Vol. 10, pS9 

    An abstract of the article "Paraoxonase Activity (PXa) Correlates with Anticardiolipin Antibodies in APS," is presented. The study aims to determine the relationship between anticardiolipin antibodies and Paraoxonase activity in patients with antiphospholipid syndrome and Systemic Lupus...

  • Prediction of Antiphospholipid syndrome using Annexin A5 competition assay in patients with SLE. Avriel, Avital; Fleischer, Stela; Friger, Michael; Shovman, Ora; Neuman, Gal; Shoenfeld, Yehuda; Abu-Shakra, Mahmoud // Clinical Rheumatology;Dec2016, Vol. 35 Issue 12, p2933 

    A significantly high correlation between reduced activity of Annexin A5 by the flow cytometric assay (FCA) and the diagnosis of antiphospholipid syndrome (APS) has been reported. The aim of this study was to assess the clinical and laboratory significance of the Annexin A5 competition assay...

  • Prednisone.  // Reactions Weekly;6/25/2011, Issue 1357, p28 

    The article describes the case of a 35-year-old woman with systemic lupus erythematosus (SLE) who developed laryngeal histoplasmosis while receiving prednisone.

  • Elevated plasminogen activator inhibitor type-1 (PAI-1) as contributing factor in pathogenesis of hypercoagulable state in antiphospholipid syndrome. Singh, N.; Gupta, A.; Behera, Dibya; Dash, D. // Rheumatology International;Sep2013, Vol. 33 Issue 9, p2331 

    The aim of this study is to explore the role of plasminogen activator inhibitor type 1 (PAI-1) in primary and secondary antiphospholipid syndrome (APS). Thirty patients of APS (24 primary and 6 secondary) were recruited in the study who fulfilled the revised Sapporo criteria. Control groups...

  • Intestinal pseudo-obstruction syndrome in systemic lupus erythematosus. Zhang, J; Fang, M; Wang, Y; Mao, J; Sun, X // Lupus;Dec2011, Vol. 20 Issue 12, p1324 

    Intestinal pseudo-obstruction (IpsO) occurs in a small subgroup of patients with systemic lupus erythematosus (SLE), and has been under-recognized. The etiology and mechanisms are unclear. Herein, we report two cases. In case 1, IpsO occurred as the complication in a previously diagnosed SLE...

  • Systemic lupus erythematosus flare up manifestation as cerebral and spinal subarachnoid hemorrhage. Tang, S-C; Lee, C-F; Lee, C-W; Jeng, J-S // Lupus;Nov2011, Vol. 20 Issue 11, p1211 

    Subarachnoid hemorrhage (SAH) is an uncommon complication of systemic lupus erythematosus (SLE). Here we report a 52-year-old woman with flare up of lupus activity, manifesting as spontaneous cerebral and spinal SAH due to central nervous system vasculitis. The patient received external...

  • IMMUNOFLUORESCENCE IN MULTIPLE TISSUES UTILIZING SERUM FROM A PATIENT AFFECTED BY SYSTEMIC LUPUS ERYTHEMATOSUS. Abreu Velez, Ana Maria; Howard, Michael S.; Brzezinski, Piotr // Our Dermatology Online / Nasza Dermatologia Online;Jan2012, Vol. 3 Issue 1, p36 

    Sebaceous naevi are congenital hamartomas comprising of sebaceous glands. They usually present at birth or may appear later as single lesion. The morphology of the lesion changes around puberty when it becomes thickened and nodular. Sebaceous naevus has definite potential for malignant...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics